Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Supplemental Parenteral Nutrition in Head and Neck Cancer
NCT02236936Phase 3Terminated
- Sponsor
- Arbeitsgemeinschaft medikamentoese Tumortherapie
- Start
- Feb 2017
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of l-leucine (2 arms), sponsored by Arbeitsgemeinschaft medikamentoese Tumortherapie. Primary endpoint: Loss of body weight by more than 5% at the end of radiotherapy at 8 weeks. Started Feb 2017; status: terminated.
02
Drugs
l-leucine
Beyond the preview
Go deeper on NCT02236936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02236936.